Advancing Excellence in Thoracic Oncology: Breakthroughs and Impactful Discoveries
Advancing Excellence in Thoracic Oncology: Breakthroughs and Impactful Discoveries
1,039
Total downloads
16k
Total views and downloads
About this Research Topic
This Research Topic is closed for submissions.
Background
This Research Topic aims to shine a spotlight on the most influential and innovative research shaping the future of cancer science and clinical care. In recent years, the field of oncology has witnessed remarkable progress, driven by transformational discoveries, the rapid integration of new technologies, and the collaborative efforts of dedicated scientists and clinicians worldwide,
The thematic collection will bring together leading experts to highlight excellence across the oncology research spectrum. We welcome Original Research and Review articles that present new understandings of cancer biology, diagnostics, therapeutics, and patient care. Submissions may include but are not limited to: novel molecular and cellular mechanisms, advances in immunotherapy, precision medicine approaches, biomarker discovery, translational research, early detection strategies, and innovations in clinical management.
Our goal is to provide a platform for outstanding contributions that both deepen our understanding of cancer and drive forward new standards of excellence in research and clinical practice. By curating significant breakthroughs and impactful studies, this collection will serve as an authoritative resource for the global oncology community, inspiring ongoing innovation and collaboration.
Submission to this article collection is by invitation only. For more information email the Editorial Office: Oncology@frontiersin.org
Please note that manuscripts consisting solely of bioinformatics or computational analysis of public omics databases that are not supplemented by relevant functional validation (clinical cohort or biological validation, in vitro or in vivo) are out of scope for this Research Topic.
Keywords: cancer research, oncology, precision medicine, immunotherapy, biomarkers, translational research, cancer therapy, lung cancer
Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.